the Anatomical Reduction and Functional Recovery Effects of Two Transvaginal Apical Slings on Pelvic Organ Prolapse

Sponsor
Peking University People's Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05189665
Collaborator
(none)
124
1
2
18
6.9

Study Details

Study Description

Brief Summary

The study is a prospective study at a single institution. Investigators create strict inclusion and exclusion criteria, selecting 124 patients with POP(≥II degree and have symptoms that need operation) . 62 patients in the intervention group accept extraperitoneal high uterosacral ligament suspension. The other 62 patients in the other group accept sacrospinous ligament suspension.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Extraperitoneal high sacral ligament suspension surgery
  • Procedure: Sacrospinous ligament fixation
N/A

Detailed Description

Investigators evaluate all women's operation method, operation time, bleed volume, overactive bladder questionnaire, PFDI-20,ICIQ-SF, I-QoL, PISQ-12, PFIQ-7, UDI-6, pre- and post-operation (at 1 month, 3 months, 6months and 1 year).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
124 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Randomized Controlled Study on the Anatomical Reduction and Functional Recovery Effects of Two Transvaginal Apical Slings on Pelvic Organ Prolapse
Actual Study Start Date :
Oct 1, 2021
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Apr 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Extraperitoneal high sacral ligament suspension Group

We will recruit 62 POP patients ,and perform Surgery Extraperitoneal high sacral ligament suspension surgery on them.

Procedure: Extraperitoneal high sacral ligament suspension surgery
The extraperitoneal high sacral ligament suspension surgery is to shorten the bilateral uterosacral ligaments .

Active Comparator: Sacrospinous Ligament Suspension Group

We will recruit 62 POP patients ,and perform sacrospinous ligament suspension surgery on them.

Procedure: Sacrospinous ligament fixation
The sacrospinous ligament fixation surgery is to open the front and back peritoneum through the vagina and shorten the bilateral uterosacral ligaments.

Outcome Measures

Primary Outcome Measures

  1. changes in POP-Q score at different time nodes [pre-operation and post-operation(at 1month, 3 month, 6 month and a year)]

    Gynecological examination

Secondary Outcome Measures

  1. UDI-6 scores at different time nodes UDI-6 [pre-operation and post-operation(at 1month, 3 month, 6 month and a year)]

    Questionnaires on lower urinary tract symptoms and quality of life

  2. Postoperative urinary incontinence assessment [post-operation(at 1month, 3 month, 6 month and a year)]

    One hour pad test

  3. OABss score at different time nodes [post-operation(at 1month, 3 month, 6 month and a year)]

    Questionnaires lower urinary tract symptoms

  4. PFDI-20 score at different time nodes [post-operation(at 1month, 3 month, 6 month and a year)]

    Questionnaires on pelvic floor function and lower urinary tract symptoms and quality of life

  5. ICIQ-SF score at different time nodes [post-operation(at 1month, 3 month, 6 month and a year)]

    Questionnaires on lower urinary tract symptoms

  6. I-QoL score at different time nodes [post-operation(at 1month, 3 month, 6 month and a year)]

    Questionnaires on lower urinary tract symptoms and quality of life

  7. PISQ-12 score at different time nodes [post-operation(at 1month, 3 month, 6 month and a year)]

    Questionnaires on pelvic floor function and lower urinary tract symptoms and sexual quality of life

  8. PFIQ-7 score at different time nodes [post-operation(at 1month, 3 month, 6 month and a year)]

    Questionnaires on pelvic floor function and quality of life

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Age ≥30 years old;

pelvic organ prolapse, with or without abnormal urination or defecation or sexual disturbance, which affects the quality of life

Pelvic organ prolapse quantitation (POP-Q) is greater than or equal to Those who are in stage II and have symptoms and require surgery

The patient agrees to conduct the study and can be followed up on time.

Exclusion Criteria:

Those who cannot tolerate surgery and anesthesia

Those who need to remove the uterus

Those who have removed the uterus

Those who cannot be followed up on time.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Peking University People's Hospital Beijing Beijing China 100044

Sponsors and Collaborators

  • Peking University People's Hospital

Investigators

  • Study Chair: xiuli sun, professor, Beijing Key Laboratory of Female Pelvic Floor Disorders

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sun Xiuli, Chief Gynecology Physician, Peking University People's Hospital
ClinicalTrials.gov Identifier:
NCT05189665
Other Study ID Numbers:
  • Pkuh4
First Posted:
Jan 12, 2022
Last Update Posted:
Jan 12, 2022
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sun Xiuli, Chief Gynecology Physician, Peking University People's Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 12, 2022